Hosp. Univ. de Torrejon

Madrid 28850

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Psoriasis

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed